These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. Wagner AD; Grothe W; Haerting J; Kleber G; Grothey A; Fleig WE J Clin Oncol; 2006 Jun; 24(18):2903-9. PubMed ID: 16782930 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743 [TBL] [Abstract][Full Text] [Related]
6. Oral versus intravenous fluoropyrimidines for colorectal cancer. Chionh F; Lau D; Yeung Y; Price T; Tebbutt N Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564 [TBL] [Abstract][Full Text] [Related]
7. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Kim HS; Kim HJ; Kim SY; Kim TY; Lee KW; Baek SK; Kim TY; Ryu MH; Nam BH; Zang DY Ann Oncol; 2013 Nov; 24(11):2850-4. PubMed ID: 23942775 [TBL] [Abstract][Full Text] [Related]
8. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer. Wulaningsih W; Wardhana A; Watkins J; Yoshuantari N; Repana D; Van Hemelrijck M Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008593. PubMed ID: 26869023 [TBL] [Abstract][Full Text] [Related]
9. Second-line systemic therapy for metastatic colorectal cancer. Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439 [TBL] [Abstract][Full Text] [Related]
10. Irinotecan in the treatment of gastric cancer. Bugat R Ann Oncol; 2003; 14 Suppl 2():ii37-40. PubMed ID: 12810456 [TBL] [Abstract][Full Text] [Related]
11. Gastric cancer. Treatment of advanced disease and new drugs. Caponigro F; Facchini G; Nasti G; Iaffaioli RV Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566 [TBL] [Abstract][Full Text] [Related]
12. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis. Ter Veer E; Haj Mohammad N; van Valkenhoef G; Ngai LL; Mali RMA; Anderegg MC; van Oijen MGH; van Laarhoven HWM J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27576566 [TBL] [Abstract][Full Text] [Related]
13. [Progress in chemotherapy for advanced gastric cancer]. Xu RH; Teng KY Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823 [TBL] [Abstract][Full Text] [Related]
14. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Kucukzeybek Y; Dirican A; Erten C; Somali I; Can A; Demir L; Bayoglu IV; Akyol M; Medeni M; Tarhan MO Asian Pac J Cancer Prev; 2012; 13(6):2771-4. PubMed ID: 22938457 [TBL] [Abstract][Full Text] [Related]
15. Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis. Cho YH; Yoon SY; Kim SN Cancer Res Treat; 2017 Jan; 49(1):255-262. PubMed ID: 27188198 [TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy for advanced gastric cancer. Wöhrer SS; Raderer M; Hejna M Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058 [TBL] [Abstract][Full Text] [Related]
17. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Ann Oncol; 2014 Jul; 25(7):1373-1378. PubMed ID: 24728035 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis. Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group. Stewart L; Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]